Contact Grace

Speaking Engagements

  

The 2023 Microbiome & Probiotics R&D and Business Collaboration Forum comes at an exciting time for the microbiome industry. The recent FDA approvals for Seres Therapeutics and MaaT Pharma (Phase III Clinical Trial), along with Vedanta Biosciences’ successful fundraising highlight the industry’s potential for a range of therapeutic applications, in

19-20 October 2023
  

It is an exciting time for the microbiome industry and recent FDA approvals and successful fundraising point towards the industry’s potential for therapeutic applications. Developments in the Skin space such as partnerships, collaboration, and licensing agreements, are all designed to boost companies’ product ranges. For example, in 2022 BioGaia an

19-20 October 2023